Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
103140.KS Stock Summary
Top 10 Correlated ETFs
103140.KS
In the News
103140.KS Financial details
Company Rating
Neutral
Market Cap
1312.45B
Income
156.44B
Revenue
4125.26B
Book val./share
71975.34
Cash/share
15723.84
Dividend
-
Dividend %
-
Employees
2.7K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
6.47
Forward P/E
7.06
PEG
-7.71
P/S
0.26
P/B
0.53
P/C
3.21
P/FCF
3.4
Quick Ratio
-
Current Ratio
1.79
Debt / Equity
0.36
LT Debt / Equity
0.12
-
-
EPS (TTM)
5.73K
EPS next Y
7158
EPS next Q
844
EPS this Y
-8.39%
EPS next Y
24.98%
EPS next 5Y
24.98%
EPS last 5Y
55.55%
Revenue last 5Y
10.97%
Revenue Q/Q
19.65%
EPS Q/Q
79.29%
-
-
-
-
SMA20
17.7%
SMA50
30.72%
SMA100
37.58%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
8%
ROC
0.09%
Gross Margin
10%
Oper. Margin
5%
Profit Margin
4%
Payout
-
Shs Outstand
27.31M
Shs Float
15.19M
-
-
-
-
Target Price
-
52W Range
31750.0-51300.0
52W High
-1.56%
52W Low
+59.06%
RSI
73
Rel Volume
0.87
Avg Volume
298.75K
Volume
260.72K
Perf Week
7.1%
Perf Month
31.68%
Perf Quarter
58.31%
Perf Half Y
45.32%
-
-
-
-
Beta
1.013
-
-
Volatility
1097.07%, 3603.95%
Prev Close
0.4%
Price
50500
Change
-0.2%
103140.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 87.52K | 92.6K | 125.28K | 159.68K | 151.03K | |
Net income per share | 629 | 2.57K | 8.69K | 6.4K | 5.73K | |
Operating cash flow per share | 7.2K | 4.09K | -695.24 | 4.99K | 26.49K | |
Free cash flow per share | 5K | 2.28K | -3.95K | 705.52 | 21.45K | |
Cash per share | 2.74K | 3.07K | 4.7K | 6.41K | 15.72K | |
Book value per share | 49.33K | 51.57K | 60.1K | 67.19K | 71.98K | |
Tangible book value per share | 48.71K | 51.04K | 59.64K | 66.85K | 71.52K | |
Share holders equity per share | 49.33K | 51.57K | 60.1K | 67.19K | 71.98K | |
Interest debt per share | 30.34K | 27.66K | 34.3K | 37.85K | 27.07K | |
Market cap | 666.63B | 782.81B | 872.59B | 902.36B | 1062.53B | |
Enterprise value | 1416.1B | 1457.17B | 1688.37B | 1751.64B | 1357.35B | |
P/E ratio | 37.84 | 10.89 | 3.59 | 5.15 | 6.79 | |
Price to sales ratio | 0.27 | 0.3 | 0.25 | 0.21 | 0.26 | |
POCF ratio | 3.31 | 6.84 | -44.8 | 6.61 | 1.47 | |
PFCF ratio | 4.76 | 12.27 | -7.88 | 46.7 | 1.81 | |
P/B Ratio | 0.48 | 0.54 | 0.52 | 0.49 | 0.54 | |
PTB ratio | 0.48 | 0.54 | 0.52 | 0.49 | 0.54 | |
EV to sales | 0.58 | 0.56 | 0.48 | 0.4 | 0.33 | |
Enterprise value over EBITDA | 8.72 | 6.45 | 3.76 | 4.97 | 4.25 | |
EV to operating cash flow | 7.02 | 12.73 | -86.69 | 12.83 | 1.88 | |
EV to free cash flow | 10.1 | 22.84 | -15.25 | 90.66 | 2.32 | |
Earnings yield | 0.03 | 0.09 | 0.28 | 0.19 | 0.15 | |
Free cash flow yield | 0.21 | 0.08 | -0.13 | 0.02 | 0.55 | |
Debt to equity | 0.59 | 0.52 | 0.56 | 0.55 | 0.36 | |
Debt to assets | 0.32 | 0.3 | 0.3 | 0.3 | 0.19 | |
Net debt to EBITDA | 4.61 | 2.99 | 1.82 | 2.41 | 0.92 | |
Current ratio | 1.63 | 1.74 | 1.68 | 1.8 | 1.66 | |
Interest coverage | 2.11 | 5.79 | 16.7 | 7.13 | 5.57 | |
Income quality | 7.65 | 1.16 | -0.06 | 0.62 | 4.62 | |
Dividend Yield | 0.03 | 0.01 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.96 | 0.16 | 0.07 | 0.16 | 0.17 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.3 | -0.44 | 4.68 | -0.86 | -0.19 | |
Capex to revenue | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -0.62 | -0.5 | -0.93 | -1.24 | -1.52 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 26.42K | 54.58K | 108.38K | 98.33K | 96.31K | |
ROIC | 0.02 | 0.04 | 0.09 | 0.06 | 0.07 | |
Return on tangible assets | 0.01 | 0.03 | 0.08 | 0.05 | 0.04 | |
Graham Net | -15.11K | -10.9K | -11.82K | -10.97K | -8.48K | |
Working capital | 481.83B | 554.73B | 750.62B | 895.27B | 887.24B | |
Tangible asset value | 1364.36B | 1429.61B | 1670.8B | 1830.78B | 1953.52B | |
Net current asset value | 66.48B | 196.38B | 396.83B | 460.19B | 544.76B | |
Invested capital | 0.59 | 0.52 | 0.56 | 0.55 | 0.36 | |
Average receivables | 403.09B | 401.95B | 484.83B | 588.67B | 596.59B | |
Average payables | 99.26B | 84B | 110.73B | 113.04B | 140.82B | |
Average inventory | 830.44B | 789.99B | 986.9B | 1193.87B | 1215.77B | |
Days sales outstanding | 56.35 | 59.87 | 56.6 | 52.85 | 49.55 | |
Days payables outstanding | 11.89 | 14.81 | 15.43 | 9.23 | 18.17 | |
Days of inventory on hand | 127.32 | 124.21 | 143.51 | 112.39 | 122.04 | |
Receivables turnover | 6.48 | 6.1 | 6.45 | 6.91 | 7.37 | |
Payables turnover | 30.69 | 24.64 | 23.66 | 39.55 | 20.08 | |
Inventory turnover | 2.87 | 2.94 | 2.54 | 3.25 | 2.99 | |
ROE | 0.01 | 0.05 | 0.14 | 0.1 | 0.08 | |
Capex per share | -2.19K | -1.81K | -3.26K | -4.28K | -5.04K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 41.48K | 38.25K | 37.93K | 34.08K | 40.77K | |
Net income per share | 1.49K | 1.99K | 1.65K | 750.75 | 1.35K | |
Operating cash flow per share | 3.53K | 7.95K | 3.39K | -1.9K | 16.04K | |
Free cash flow per share | 2.47K | 6.05K | 2.32K | -2.94K | 15.01K | |
Cash per share | 6.43K | 7.09K | 6.78K | 6.21K | 15.72K | |
Book value per share | 67.37K | 68.87K | 70.45K | 71.48K | 71.98K | |
Tangible book value per share | 67.03K | 68.53K | 70.04K | 71.04K | 71.52K | |
Share holders equity per share | 67.37K | 68.87K | 70.45K | 71.48K | 71.98K | |
Interest debt per share | 37.14K | 32.54K | 29.6K | 31.87K | 25.89K | |
Market cap | 899.98B | 1032.48B | 1185.44B | 923.22B | 1062.53B | |
Enterprise value | 1749.26B | 1729.65B | 1814B | 1631.67B | 1357.35B | |
P/E ratio | 5.52 | 4.76 | 6.59 | 11.26 | 7.23 | |
Price to sales ratio | 0.79 | 0.99 | 1.14 | 0.99 | 0.95 | |
POCF ratio | 9.33 | 4.75 | 12.79 | -17.81 | 2.43 | |
PFCF ratio | 13.33 | 6.25 | 18.7 | -11.5 | 2.59 | |
P/B Ratio | 0.49 | 0.55 | 0.62 | 0.47 | 0.54 | |
PTB ratio | 0.49 | 0.55 | 0.62 | 0.47 | 0.54 | |
EV to sales | 1.54 | 1.66 | 1.75 | 1.75 | 1.22 | |
Enterprise value over EBITDA | 35.67 | 13.39 | 17.25 | 20.75 | 17.12 | |
EV to operating cash flow | 18.14 | 7.96 | 19.57 | -31.48 | 3.1 | |
EV to free cash flow | 25.91 | 10.46 | 28.61 | -20.33 | 3.31 | |
Earnings yield | 0.05 | 0.05 | 0.04 | 0.02 | 0.03 | |
Free cash flow yield | 0.08 | 0.16 | 0.05 | -0.09 | 0.39 | |
Debt to equity | 0.55 | 0.46 | 0.41 | 0.44 | 0.36 | |
Debt to assets | 0.3 | 0.26 | 0.24 | 0.25 | 0.19 | |
Net debt to EBITDA | 17.32 | 5.4 | 5.98 | 9.01 | 3.72 | |
Current ratio | 1.8 | 1.89 | 1.74 | 1.79 | 1.66 | |
Interest coverage | 2.46 | 5.98 | 5.33 | 3.16 | 6.55 | |
Income quality | 6.76 | 3.07 | 1.74 | -1.92 | 11.91 | |
Dividend Yield | 0.03 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0.69 | 0 | 0.61 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.04 | 0.05 | 0.05 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0.01 | 0.01 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.3 | -0.24 | -0.32 | 0.55 | -0.06 | |
Capex to revenue | -0.03 | -0.05 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -1.21 | -2.27 | -1.29 | -1.25 | -1.32 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 47.54K | 55.47K | 51.07K | 34.75K | 46.69K | |
ROIC | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -11K | -9.64K | -8.14K | -9.34K | -8.48K | |
Working capital | 895.27B | 942.17B | 840.32B | 909.04B | 887.24B | |
Tangible asset value | 1830.78B | 1871.92B | 1912.97B | 1940.51B | 1953.52B | |
Net current asset value | 460.19B | 506.13B | 538.93B | 565.75B | 544.76B | |
Invested capital | 0.55 | 0.46 | 0.41 | 0.44 | 0.36 | |
Average receivables | 637.77B | 590.85B | 538.6B | 543.89B | 559.57B | |
Average payables | 100.68B | 131.72B | 166.8B | 157.56B | 164.41B | |
Average inventory | 1260.77B | 1234.17B | 1260.78B | 1284.05B | 1268.93B | |
Days sales outstanding | 50.29 | 47.25 | 45.93 | 54.06 | 45.26 | |
Days payables outstanding | 8.73 | 16.17 | 16.35 | 15.43 | 16.75 | |
Days of inventory on hand | 106.36 | 124.23 | 121.59 | 138.42 | 112.46 | |
Receivables turnover | 1.79 | 1.9 | 1.96 | 1.66 | 1.99 | |
Payables turnover | 10.31 | 5.56 | 5.51 | 5.83 | 5.37 | |
Inventory turnover | 0.85 | 0.72 | 0.74 | 0.65 | 0.8 | |
ROE | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | |
Capex per share | -1.06K | -1.9K | -1.07K | -1.04K | -1.03K |
103140.KS Frequently Asked Questions
What is Poongsan Corporation stock symbol ?
Poongsan Corporation is a KR stock and trading under the symbol 103140.KS
What is Poongsan Corporation stock quote today ?
Poongsan Corporation stock price is $50500 today.
Is Poongsan Corporation stock public?
Yes, Poongsan Corporation is a publicly traded company.